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Long-term acute care hospitals (LTACs) are acute care facili-
ties that provide care for chronically critically ill patients for 
an extended period of time, typically greater than 25 days.1 
LTACs may best be known for intense respiratory care where 
patients are mechanically ventilated and, ideally, weaned 
from such care. The needs of LTAC patients are complex; 
hence, LTACs are an expensive setting of care. Medicare 
spent US$39,000 per LTAC visit in 2011,1 compared to 
1997, when the median case cost was US$28,499.2 Because 
Medicaid coverage of LTACs is optional for states, coverage 
and reimbursement of LTAC services differ between 
Medicaid programs and merits further research. Georgia 
Medicaid does not distinguish between LTACs and other 
hospitals. Therefore, participating LTACs are reimbursed 
through the same diagnosis-related group (DRG) methodol-
ogy used for all Georgia hospitals; there are no separate rules 
or requirements for LTAC coverage.3
The majority of research on LTACs has drawn from sam-
ples of Medicare patients, with very few studies that include 
a Medicaid population. Findings on the costs and outcomes 
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experienced by Medicare patients who received care at an 
LTAC are mixed. Kahn and Carson4 found that a transfer to 
an LTAC was associated with lower post-acute care (PAC) 
(US$9463 lower) and total (US$13,442 lower) costs, but 
higher overall Medicare payments (US$15,592 higher). A 
study commissioned by the Centers for Medicare and 
Medicaid Services (CMS) found that patients referred to 
LTACs had higher costs and higher payments compared to 
similar patients who were not transferred to LTACs, but that 
the magnitude of the difference varied by the patient’s pri-
mary diagnosis.5 Despite the additional costs, studies have 
yet to conclusively show that LTAC-level care leads to desir-
able outcomes, including shortened lengths of stay, lower 
mortality, or fewer readmissions.1,6–10
New contribution
The nearly exclusive focus of the current LTAC research on 
the Medicare population and program has resulted in a dearth 
of studies on LTAC services for the Medicaid population. To 
our knowledge, only two studies have focused on LTAC care 
for Medicaid beneficiaries. A report on California Medicaid’s 
program found that in 2008, 4463 dual-eligible Californians 
received care at an LTAC at an average cost of US$51,446 
per patient (all Medicare spending).11 In another descriptive 
analysis, Liu et al.2 reported that in 1997, 9.4% of all LTAC 
discharges nationally were for Medicaid beneficiaries. The 
authors also noted that the median length of stay for Medicaid 
patients was 40.2 days, compared to 30.4 days for Medicare 
beneficiaries.
This gap in the literature is important because outcomes, 
costs, and utilization of Medicare beneficiaries at LTACs 
may not be representative of the Medicaid population. With 
very little research on Medicaid beneficiaries and LTACs, 
state policy makers are left with evidence that is potentially 
not representative of the population for which they are mak-
ing coverage decisions. Furthermore, given that patients who 
receive care at LTACs are some of the most high-cost/high-
need beneficiaries, policy makers should place an emphasis 
on this population if they hope to lower costs for their 
Medicaid program. Knowing which Medicaid populations 
receive care from LTACs and their associated outcomes 
could inform coverage decisions, payment models, prior 
authorization criteria, and coordination of care initiatives for 
state Medicaid programs. In addition, if many Medicaid 
LTAC patients are also eligible for Medicare, this research 
could inform federal–state joint policies intended to improve 
care for this vulnerable population.
Research objective
The objective of this research is to describe the Georgia 
Medicaid population who received care at an LTAC, the type 
and volume of services provided by these LTACs, and the 
costs and outcomes associated with these services. For those 
with select respiratory conditions, we also compare costs and 
outcomes to those of patients who received care for the same 
services in acute care hospitals (ACHs).
Our research builds on the premise that patients with 
select respiratory conditions may experience improved out-
comes when receiving specialized care as compared to simi-
lar patients who receive non-specialized care. As mentioned 
previously, LTACs are unique in that they provide intense 
respiratory care for patients who require prolonged mechani-
cal ventilation.12 LTACs, as opposed to intensive care units 
(ICUs), may offer specialized multidisciplinary teams, 
advanced weaning protocols, and experience with a niche 
group of patients with similar and complex needs.4 ICUs, on 
the other hand, may be more likely to stabilize the patient but 
serve a far greater variety of patient needs, thereby limiting 
their ability to specialize their care on one group.4
Our comparative analysis focuses on a subset of the 
Medicaid population with select respiratory conditions. We 
seek to understand both the differences in the demographic 
and cost characteristics of those who are admitted to an 
LTAC as compared to those who receive care in alternative 
settings. Our work adds to that of previous studies, focused 
on Medicare patients, by assessing the value of LTACs for a 
different group of complex patients.
Methods
Data sources and study sample
We used Georgia Medicaid claims data from January 2011 
through December 2012. Our study sample consisted of fee-
for-service Medicaid members who were admitted to an 
LTAC. As of 1 July 2011, 39% of Georgia Medicaid mem-
bers were enrolled in fee-for-service Medicaid.13
Study design and measures. We performed a descriptive anal-
ysis to better understand the demographic characteristics, 
primary diagnoses, and total Medicaid costs for Medicaid 
patients who were served by LTACs. We constructed 90-day 
episodes of care based on an ACH visit that immediately led 
to an LTAC stay. (Start dates for the 90-day episode began at 
the LTAC visit for patients who were not transferred from an 
ACH.) This is a common approach in the literature as this 
patient population has complex needs and is commonly 
served by multiple facilities.5,14 We then performed an out-
comes’ analysis of Medicaid members with one or more 
LTAC visits, including length of stay, place of discharge, 
30-day hospital readmissions, and per-patient costs for 
patients admitted by each LTAC covered by the Georgia 
Medicaid program. (We excluded episodes where the patient 
was discharged to multiple LTACs within the same episode 
and all episodes that began on 30 September 2012 or later.) 
We determined the average length of stay at the originating 
ACH and the patient’s time at the LTAC. The place of dis-
charge variable included five potential settings: (1) ACH; (2) 
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PAC facility, which includes skilled nursing and inpatient 
rehabilitation facilities; (3) community, where the patient 
was discharged home or to a home health service; (4) death; 
and (5) all other. We defined 30-day readmissions as an 
admission to an ACH within 30 days of being discharged to 
the community. Readmissions that occurred beyond the 
90-day episode window but were within 30 days of discharge 
were included. We limited our cost measures to patients who 
survived the 90-day episode and excluded dual-eligibles. 
Our data included only Medicaid costs; thus, cost estimates 
for dual-eligibles would have been inaccurate as the amount 
paid by Medicare was unobserved. Costs captured all Med-
icaid reimbursed medical payments for services beginning 
within the 90-day episode.
Finally, we conducted a comparative analysis to meas-
ure differences in outcomes and costs for patients with 
similar conditions who received care at an LTAC, com-
pared with patients who remained at an ACH. We again 
analyzed the length of stay, place of discharge, 30-day hos-
pital readmissions, and per-patient costs for patients in both 
these settings and tested for statistical significance between 
both groups for each variable. We focused on episodes that 
originated at the ACH and had no previous LTAC or skilled 
nursing facility admissions during the 2-year time frame. 
ACHs were selected if the facility was located within or 
bordering the counties in which any of the LTACs are 
located. In order to create similar samples between the 
ACH and the LTAC, we retained only admissions with at 
least a 14-day length of stay and limited our comparative 
analysis sample to admissions for one of five respiratory-
related DRGs. These five DRGs constituted approximately 
45% of all Georgia Medicaid LTAC admissions and 
included the following: (All DRG codes are from the 
Tricare version 30 DRG grouper.)
•• DRG 542—tracheostomy with mechanical ventila-
tion for more than 96 h or principal diagnosis except 
face, mouth, and neck
•• DRG 565—respiratory system diagnosis with ventila-
tor support for more than 96 h
•• DRG 87—pulmonary edema and respiratory failure
•• DRG 541—extracorporeal membrane oxygenation or 
tracheostomy with mechanical ventilation for more 
than 96 h or principal diagnosis except face, mouth, 
and neck with major operating room procedure
•• DRG 566—respiratory system diagnosis with ventila-
tor support for less than 96 h
To examine differences in severity of illness between 
ACH and LTAC patients, we calculated the Chronic Illness 
and Disability Payment System + Rx (CDPS + Rx) score 
using 2011 and 2012 claims data. The CDPS + Rx incorpo-
rates demographic information, 15,000 International 
Classification of Diseases (ICD)-9 codes, and pharmacy data 
into diagnostic buckets in order to generate a risk score for 
each patient.15–17 We report average CDPS + Rx risk scores 
for each setting of care. As a sensitivity analysis, we restricted 
the range of conditions to conduct a sub-analysis using only 
one DRG (565—respiratory system diagnosis with ventilator 
support for more than 96 h).
This research was reviewed and approved by the Georgia 
State University Institutional Review Board.
Results
Descriptive analysis
We identified six LTACs that provided services to Medicaid 
members between 2011 and 2012. One LTAC specialized in 
neurological and spine care. Given that the diagnoses served 
by this LTAC were substantially different than the other five 
LTACs, and that respiratory care is more common nationally 
at LTACs,18 we excluded this facility from the remainder of 
the analysis. The remaining five LTACs provided inpatient 
services for 458 Medicaid patients during the study period 
(see Table 1). Seventy-one percent of these patients were eli-
gible for Medicaid due to blindness or disability. While 
approximately 52% of patients receiving LTAC inpatient 
services were dually eligible for both Medicaid and Medicare, 
the average age of patients receiving LTAC services was 
56 years old. We calculated the total 2-year Medicaid expen-
ditures for non-dual members who received care from an 
LTAC as a benchmark for their total Medicaid costs. The 
median total Medicaid cost for these members was 
US$149,312. The range of expenditures was wide, from 
US$86,811 in the 25th percentile to US$242,927 in the 75th 
percentile.
Outcomes analysis
The five LTACs admitted 458 patients for 470 episodes, 
ranging from 46 to 258 episodes at each LTAC. Overall, 
37.2% of the patients were discharged to another PAC, and 
34.3% were discharged to the community. Just over 10% 
were discharged back to an ACH, 12.3% died, and 5.5% had 
other discharge statuses. Of the 161 patients who were dis-
charged to the community, 38 (23.6%) were readmitted to an 
ACH within 30 days. There were 47 readmissions among 
these 38 patients, indicating multiple readmissions for cer-
tain patients.
The average length of stay at an ACH prior to discharge to 
an LTAC was 20 days. Once at the LTAC, Medicaid patients 
stayed for 36 days on average. Among the five LTACs, the 
average length of stay ranged from 29 to 40 days.
The average overall cost of a 90-day episode for a non-
dual not deceased Medicaid member, including ACH, LTAC, 
and other costs, was US$119,795. This figure includes aver-
age ACH costs of US$69,676, LTAC costs of US$46,805, 
and all other costs (including any outpatient services at any 
provider) of US$3313.
 at GEORGIA STATE UNIVERSITY on October 4, 2016smo.sagepub.comDownloaded from 
4 SAGE Open Medicine
Comparative analysis
The LTACs treated 211 respiratory-related episodes for 208 
patients in 2011 and 2012 (see Table 2) compared to 821 
episodes for 808 patients at ACHs. Patients who were treated 
at an LTAC were older and more likely to be eligible for 
Medicaid through a disability and had higher risk scores on 
average than patients who remained in the ACH. The aver-
age risk score among the patients treated at an LTAC was 
13.1, compared to 9.0 for patients who stayed at the ACH 
(p < 0.01). While the distribution of the five DRGs was dif-
ferent between the ACH and LTAC groups, the risk scores 
within each DRG were significantly higher for those that 
received care at an LTAC.
Among the comparison group, 51.8% of episodes at 
ACHs resulted in a discharge to the community, compared to 
28.4% of LTAC admissions (p < 0.01; see Table 2). LTACs 
discharged patients more frequently to another PAC (37.4% 
versus 13.9%; p < 0.01), while a greater proportion of ACH 
patients died before being discharged (18.2% versus 15.6%; 
p < 0.01). Of the 425 patients discharged to the community 
from ACHs, 87 (20.5%) were readmitted within 30 days of 
discharge. However, because there were 105 total readmis-
sions, it is clear that some patients experienced multiple 
readmissions. LTACs discharged 60 patients (28.4%) to the 
community, 14 (23.3%) of whom were readmitted within 
30 days of discharge for 18 total readmissions. Differences in 
readmissions rates between ACHs and LTACs were not sta-
tistically significant.
Non-deceased patients who received all their care at the 
ACH had an average length of stay of 38 days, compared to 
non-deceased patients admitted to an LTAC who had an 
average length of stay of 19 days at the ACH followed by 
42 days at the LTAC (see Table 3). The length of stay at the 
ACH varied by discharge location. For example, those indi-
viduals discharged to the community from the ACH or LTAC 
had an average length of stay of 37 and 56 days, respectively, 
compared to those discharged to a PAC (42 and 64 days). 
Among non-dual not deceased patients, the average total 
cost of a 90-day episode at an LTAC was US$143,898, com-
pared to US$115,056 for patients who remained at the ACH. 
Costs related to the original hospitalization and post-dis-
charge from the LTAC were lower on average for LTAC 
patients compared to those that remained at the ACH.
The results of the sensitivity analysis using only DRG 
565 were consistent with the comparative analysis presented 
above (data not shown). Among 73 LTAC and 202 ACH epi-
sodes, a greater proportion of patients at ACHs were dis-
charged to the community (59.7% versus 32.9%). The 
average combined inpatient length of stay was 59 days at 
LTACs versus 25 days at ACHs. Readmission rates were 
higher among LTAC patients (20.8%) than ACHs (13.0%), 
although sample sizes were small (24 and 123 patients were 
discharged to the community, respectively). Finally, average 
90-day costs among non-dual not deceased patients were 
higher at LTACs (US$169,467) than at ACHs (US$76,304).
Discussion
Due to a lack of studies in the literature, little is known about 
the population of Medicaid patients who receive care at LTACs. 
Even less is known about the costs or outcomes of their care. 
Our study contributes to the literature on LTAC patients by 
describing the Medicaid population in Georgia who receive 
Table 1. Descriptive characteristics, outcomes, and costs of 
patients who received LTAC inpatient services.
Descriptive characteristics
Number of patients    458
Number of 90-day episodes    470
Eligibility type, n (%)
 Aged 60 (13.1)
 Blind and disabled 326 (71.2)
 Medically needy 12 (2.6)
 Other 60 (13.1)
Dual status, n (%)
 Dual 239 (52.2)
 Non-dual 219 (47.8)
Age (years)
 Average (SD) 56.5 (15.1)
 Age 0–64, n (%) 333 (72.7)
 Age >64, n (%) 125 (27.3)
Gender, n (%)
 Male 202 (44.1)
 Female 256 (55.9)
Outcomes
Discharge status, n (%)
 ACH 50 (10.4)
 PAC 175 (37.2)
 Community 161 (34.3)
 Died 58 (12.3)
 All other 26 (5.5)
Readmissionsa 38 (23.6)
Average length of stay (days)
 Original ACH (SD)b 20 (15.4)
 LTAC (SD) 36 (22.2)
 Total (SD) 56 (28.0)
Costsc
Number of patients 187
Number of episodes 194
Avg. total cost per episode (US$)  
 Hospital care (SD) 69,676 (59,262)
 LTAC care (SD) 46,805 (31,110)
 Other (SD) 3313 (4119)
 Total (SD) 119,795 (64,852)
SD: standard deviation; ACH: acute care hospital; PAC: post-acute care; 
LTAC: long-term acute care hospital.
aReadmissions were calculated only for patients who were discharged to 
the community.
bOriginal ACH only includes patient who were transferred to an LTAC 
from an ACH.
cNumber of episodes are for non-dual and non-deceased patients.
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care at LTACs. We also compared costs and outcomes for 
Medicaid patients receiving select respiratory care in LTACs as 
opposed to those receiving similar care in an ACH.
Our study revealed that the Medicaid population seeking 
care at LTACs is markedly different than the Medicare 
populations described in other LTAC studies, not just based 
on patient age. Of the Medicaid patients who received care in 
Georgia LTACs during the study period, we found that 71% 
of them were blind or disabled. Our study also showed more 
patients discharged to the community (34.3%) than prior 
Table 2. Comparison of risk scores, discharge status, and readmissions for patients who received ACH only versus ACH and LTAC 
inpatient services for select respiratory conditions.
Facility type
 ACH only ACH and LTAC
Descriptive characteristics
Number of patients 808 208
Eligibility type, n (%)
 Aged 46 (6) 17 (8)**
 Blind and disabled 589 (73) 177 (85)**
 Medically needy 88 (11) Suppressed
 Other 84 (10) Suppressed
Dual status, n (%)
 Dual 218 (27) 61 (29)
 Non-dual 589 (73) 147 (71)
Age (years)
 Average (SD) 45 (20.4) 56 (14.0)**
 Age 0–64, n (%) 709 (88) 170 (82)**
 Age >64, n (%) 98 (12) 38 (18)**
Gender, n (%)
 Male 402 (50) 94 (45)
 Female 405 (50) 114 (55)
Average risk score (SD)a 9.0 (3.6) 13.1 (3.4)**
Outcomes
Number of 90-day episodes 821 211
Episodes by diagnosis-related group n (%) Average risk score (SD) n (%) Average risk score (SD)
DRG 542 214 (26) 9.04 (3.52) 79 (37)** 13.29 (3.81)**
DRG 565 203 (25) 9.10 (3.68) 71 (34)** 12.66 (2.87)**
DRG 87 55 (7) 9.34 (3.11) 30 (14)** 13.33 (3.45)**
DRG 541 271 (33) 9.27 (3.80) 19 (9)** 14.16 (3.39)**
DRG 566 78 (10) 8.36 (3.57) 12 (6)** 12.05 (3.74)**
Discharge status, n (%)
 ACH 15 (1.8) 26 (12.3)**
 PAC 114 (13.9) 79 (37.4)**
 Community 425 (51.8) 60 (28.4)**
 Died 149 (18.2) 33 (15.6)**
 All other 118 (14.4) 13 (6.2)**
Readmissionsb 87 (20.5) 14 (23.3)
ACH: acute care hospital; LTAC: long-term acute care hospital; SD: standard deviation; CDPS + Rx: Chronic Illness and Disability Payment System + Rx.
Tests of statistical significance for discharge status and readmissions are chi-squared tests. A two-tailed t-test was used for differences in average risk 
scores. Certain figures are suppressed to protect patient confidentiality because of low observation numbers.
DRG 542—tracheostomy with mechanical ventilation for more than 96 h or principal diagnosis except face, mouth, and neck.
DRG 565—respiratory system diagnosis with ventilator support for more than 96 h.
DRG 87—pulmonary edema and respiratory failure.
DRG 541—extracorporeal membrane oxygenation or tracheostomy with mechanical ventilation for more than 96 h or principal diagnosis except face, 
mouth, and neck with major operating room procedure.
DRG 566—respiratory system diagnosis with ventilator support for less than 96 h.
a CDPS + Rx scores were calculated for 807 patients who remained at the ACH.
b Readmissions were calculated only for patients who were discharged to the community.
**p < 0.01.
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Table 3. Comparison of length of stay and costs for patients 
who received ACH only versus ACH and LTAC inpatient 
services for select respiratory conditions, by discharge location.
Discharge 
location
Facility type
ACH only ACH and LTAC
Overall
Average length of 
stay (SD), days
N = 672 N = 178
 At ACH 38 (28.6) 19 (14.7)**
 At LTAC – 42 (24.4)
 Total 38 (28.6) 61 (28.2)**
Average cost 
(SD), US$
N = 481 N = 126
 ACH care 110,997 (110,438) 82,631 (53,184)**
 LTAC care – 58,384 (29,986)
 Other 4059 (6794) 2883 (3465)**
 Total 115,056 (109,802) 143,898 (50,934)**
ACH
Average length of 
stay (SD), days
N = 15 N = 26
 At ACH 28 (15.0) 21 (22.5)
 At LTAC – 31 (24.0)
 Total 28 (15.0) 52 (32.0)**
Average cost 
(SD), US$
N = suppressed N = suppressed
 ACH care 149,532 (101,175) 103,106 (58,902)
 LTAC care – 66,308 (33,242)
 Other 890 (885) 3046 (4667)*
 Total 150,423 (101,225) 172,460 (59,066)
PAC
Average length of 
stay (SD), days
N = 114 N = 79
 At ACH 42 (28.5) 18 (11.1)**
 At LTAC – 47 (25.5)
 Total 42 (28.5) 64 (27.5)**
Average cost 
(SD),US$
N = 66 N = 51
 ACH care 137,737 (95,198) 80,066 (56,065)**
 LTAC care – 62,200 (30,918)
 Other 2007 (3562) 4096 (3947)**
 Total 139,744 (94,586) 146,362 (50,285)
Community
Average length of 
stay (SD), days
N = 425 N = 60
 At ACH 37 (28.3) 19 (11.2)**
 At LTAC – 38 (20.7)
 Total 37 (28.3) 56 (22.6)**
Average cost 
(SD), US$
N = 338 N = suppressed
 ACH care 100,925 (97,962) 74,485 (45,998)**
 LTAC care – 50,881 (26,952)
 Other 4447 (6956) 1848 (2114)**
 Total 105,372 (97,653) 127,214 (42,783)**
Other
Average length of 
stay (SD), days
N = 118 N = 13
 At ACH 37 (30.5) 25 (25.8)
Discharge 
location
Facility type
ACH only ACH and LTAC
 At LTAC – 55 (24.1)
 Total 37 (30.5) 81 (37.8)**
Average cost 
(SD), US$
N = 66 N = suppressed
 ACH care 129,419 (166,808) 106,023 (56,349)
 LTAC care – 64,354 (30,710)
 Other 4654 (8371) 1465 (1700)**
 Total 134,073 (165,479) 171,842 (51,877)
ACH: acute care hospital; LTAC: long-term acute care hospital; SD: 
standard deviation; PAC: post-acute care.
Tests of statistical significance between overall ACH only and ACH and 
LTAC are two-tailed t-tests. Length of stay totals may not sum correctly 
due to rounding errors. Length of stays include non-deceased patients 
only, and costs include non-deceased and non-dual patients only. Certain 
figures are suppressed to protect patient confidentiality because of low 
observation numbers.
*p < 0.1; **p < 0.01.
Table 3. (Continued)
studies of Medicare patients (22%),6 as well as a much lower 
mortality rate—12.3% as opposed to 48.2%−52.2% found 
by Kahn et al.7 However, we found readmissions and costs to 
be higher for Medicaid patients than those found in prior 
studies of Medicare patients.2,7,9 In fact, the average episode 
payments to an LTAC were approximately 20% higher for 
this population than Medicare’s average payment in 2011 
(US$46,805 versus US$39,000).1 Although many reasons 
may exist for these differences, they demonstrate that prior 
research using Medicare patients may not be appropriate for 
informing state Medicaid policy for LTAC coverage.
In addition to differences with the Medicare population, 
our study also revealed that Medicaid patients receiving 
select respiratory care at an LTAC were distinct from 
Medicaid patients receiving similar care at an ACH. We 
found marked differences in terms of patient condition, dis-
charge location, length of stay, and costs. In fact, our com-
parison of risk scores (both overall and within DRGs) shows 
that these Medicaid patients are more seriously ill than those 
who receive similar care at an ACH (13.1 for LTACs versus 
9 for ACHs; p < 0.01). Therefore, it appears that LTACs are 
treating a different and more complex set of Medicaid 
patients.
The results of our study also imply that the Medicaid pop-
ulation receiving care at LTACs is more likely to experience 
certain outcomes than their Medicare counterparts. This is 
born out in the higher rate of discharge to the community for 
this population (34.3%) as compared to Medicare patients 
(22%). However, it is not clear why readmission rates are 
higher for Medicaid patients. It may be that they are more 
likely to be disabled than those on Medicare or that their 
economic condition makes them less likely to seek appropri-
ate and timely follow-up care with their primary care physi-
cian. Our comparative analysis with ACH patients does show 
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LTAC Medicaid patients to have more serious conditions 
than their ACH counterparts, but we did not have informa-
tion on risk scores for Medicare patients to make similar 
comparisons.
Our results have implications for providers and policy 
makers. Although not required to do so, LTACs in Georgia 
seemed to limit their Medicaid admissions to respiratory 
cases of greater complexity than those observed in an ACH. 
It is possible that physicians and hospitals are only referring 
these difficult cases to LTACs, because they believe that 
their patients are likely to receive better care, or that LTACs 
are screening for these patients. In Georgia’s case, it may not 
be necessary for the state Medicaid agency to impose admis-
sion restrictions on LTACs. In fact, Georgia places no more 
admission restrictions on LTACs than they do for other acute 
care facilities. Finally, much of the added expense of epi-
sodes that involve an LTAC transfer can be attributed to the 
Medicaid program’s practice of paying two separate DRGs, 
which may only save costs if the transfer is able to avoid an 
outlier payment to an ACH. Therefore, Medicaid programs 
may want to consider bundled payments for LTAC transfers. 
A bundled payment would avoid paying two separate DRGs, 
would cover transfers back to the original ACH—which hap-
pened frequently in our study population (10.4%)—and 
would cover readmissions post-discharge to the community.
There are several limitations to this study. We only exam-
ined claims data for Georgia Medicaid patients enrolled in 
fee-for-service Medicaid; thus, our results may not be gener-
alizable to Medicaid patients in other states or in managed 
care. More specific to our data, we excluded episodes where 
a patient was discharged to multiple LTACs within the same 
episode. Although this was likely a very small number of 
patients, it removes a potentially informative population 
from our analysis. In addition, costs were calculated only for 
non-dual Medicaid patients, as we did not have access to 
Medicare payment information, the primary payer for dual-
eligibles. Finally, our sample size for comparative analysis 
was small, thereby limiting our ability to discuss associa-
tions between settings of care and patient outcomes. 
Additional work including modeling that controls for the 
impact of demographic and socioeconomic factors along 
with patient severity is needed for more robust discussions 
that assess the value of LTAC care on patient outcomes.
In spite of these limitations, our study found that Medicaid 
patients who receive care at an LTAC are different from 
Medicare patients, as well as Medicaid patients receiving 
comparable care at an ACH. These findings may be informa-
tive to providers and policy makers when determining who is 
best suited for LTAC care and what services Medicaid should 
cover. However, further research is needed to determine 
whether these differences between populations contribute 
significantly to the differences in outcomes and costs that we 
observed. Specifically, whether patient risk scores and other 
demographic differences are predictive of outcomes and 
costs for this population needs to be researched and ana-
lyzed. Further research should also focus on Medicaid 
patients from multiple states in order to determine whether 
our findings are generalizable to the broader Medicaid popu-
lation and thus informative for providers and state Medicaid 
policy makers in other states.
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